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Imaging regulatory T cell dynamics and
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Foxp3þ regulatory T cells (Tregs) maintain immune homoeostasis through mechanisms that
remain incompletely deﬁned. Here by two-photon (2P) imaging, we examine the cellular
dynamics of endogenous Tregs. Tregs are identiﬁed as two non-overlapping populations in the
T-zone and follicular regions of the lymph node (LN). In the T-zone, Tregs migrate more
rapidly than conventional T cells (Tconv), extend longer processes and interact with resident
dendritic cells (DC) and Tconv. Tregs intercept immigrant DCs and interact with antigen-
induced DC:Tconv clusters, while continuing to form contacts with activated Tconv. During
antigen-speciﬁc responses, blocking CTLA4-B7 interactions reduces Treg–Tconv interaction
times, increases the volume of DC:Tconv clusters and enhances subsequent Tconv
proliferation in vivo. Our results demonstrate a role for altered cellular choreography of Tregs
through CTLA4-based interactions to limit T-cell priming.
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R
egulatory T cells (Tregs) expressing the Foxp3 transcription
factor constitute a critical component of peripheral
immune homoeostasis and tolerance. Several autoimmune
and inﬂammatory pathologies in humans are associated with
functional defects in Tregs, and depletion of Tregs in experi-
mental animals leads to systemic autoimmune and allergic disease
accompanied by unchecked lymphoproliferation1–4. Expression
of an inhibitory member of the immunoglobulin super-family
cytotoxic T-lymphocyte antigen 4 (CTLA4) by Tregs is critical
for their function. The loss of Treg-speciﬁc CTLA4 expression
or treatment with a blocking antibody lead to potentially
lethal T-cell-mediated autoimmune pathology5–8. Moreover,
polymorphisms in human CTLA4 are linked to the develop-
ment of autoimmune diseases, including type I diabetes and
primary progressive multiple sclerosis9. Although it is now
established that Tregs and their expression of CTLA4 are both
indispensable for the maintenance of immune homoeostasis4–6,10,
the underlying cellular and molecular mechanisms of CTLA4-
mediated suppression are not well-understood11. In vitro studies
of T-cell cultures in the absence of antigen-presenting cells (APC)
have demonstrated that Tregs directly suppress both CD4þ and
CD8þ T-cell proliferation in a contact-dependent, antigen-
independent manner12,13. However, in vivo data are lacking on
how endogenous Tregs interact with APCs and conventional T
cells (Tconvs).
Two-photon (2P) microscopy allows detailed observation and
analysis of the spatio-temporal choreography of live cell–cell
interactions within the native tissue environment of the lymph
node (LN), secondary lymphoid organs and peripheral tis-
sues14,15. In the LN, naive CD4þ T cells exhibit three distinct
phases of behaviour in relation to dendritic cells (DCs) during
initiation of an immune response16: (1) dynamic scanning with
transient interactions with antigen-bearing DCs; (2) formation of
dynamic clusters in which multiple T cells stop migrating freely
and form stable contacts with DCs and (3) disengagement of T
cells from DCs, followed by swarming behaviour and subsequent
antigen-speciﬁc T-cell proliferation. Previous 2P imaging studies
have investigated Treg-induced suppression during T-cell
priming either by addition of in vitro-separated CD4þ CD25þ
T cells17–21 or by diphtheria toxin-induced depletion of Tregs22.
Notably, no previous studies have imaged endogenous Tregs in
the context of both Tconvs and DCs. Simultaneous and direct
imaging of endogenous Tregs together with naı¨ve T cells and DCs
would permit insight into the cellular behaviour and in vivo
mechanisms that underlie immunoregulation.
Here using 2P microscopy of LNs from Foxp3EGFPmice, we
have characterized the dynamics of unperturbed, endogenous
Tregs interacting with Tconv and with DCs under steady-state
conditions, in the presence of LPS-activated DCs as a model for
inﬂammation and during antigen-speciﬁc CD4 T-cell priming.
We further demonstrate the crucial involvement of CTLA4-B7
interactions in determining cellular dynamics among Tregs,
Tconvs and DCs in vivo.
Results
Imaging regional differences in Treg dynamics. To visualize
endogenous Treg cells, we screened mouse strains that express
ﬂuorescent proteins speciﬁc to Tregs, and identiﬁed Foxp3EGFP
mice as optimal for 2P imaging. Developed by Haribhai et al.23,
Foxp3EGFP mice contain a bicistronic Foxp3–enhanced green
ﬂuorescent protein (Foxp3–EGFP) gene that induces reliable co-
expression of EGFP and Foxp3 in bona ﬁde endogenous Tregs.
EGFPþ Tregs were clearly visualized by 2P imaging of explanted
LNs without exogenous labelling or adoptive transfer (Fig. 1a).
Mapping the distribution of Tregs with respect to CFPþ CD19þ
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Figure 1 | Endogenous Foxp3þ Treg regional behaviour and interaction
with Tconvs. (a) Tregs in inguinal lymph node from a Foxp3EGFP mouse
under steady-state conditions. Green, EGFPþ endogenous Tregs; blue,
second-harmonic collagen signal in capsular boundary. Single plane image,
scale bar, 100mm. White square represents area imaged in c. See
Supplementary Video 2. (b) T-zone and follicular Tregs (both green),
visualized 72h after adoptive transfer of CFPþCD19þ B cells (blue) and
CMTMR-labelled Tconv cells (red). Note: Tregs colocalized with B cells within
the dotted outline and at higher density with Tconv cells throughout the T-cell
zone. Scale bar, 50mm. (c) Non-overlapping populations of Tregs in the
T-zone and the follicle. Treg movements represented by tracks within (light
blue tracks) and outside the B-cell follicle (bright green). Cells tracked over
29:38 (min:s); 35-mm z-stack 50-mm tick marks. (d) Treg velocities in three
regions of the lymph node. Each circle represents mean velocity in the T-cell
zone (n¼ 174 tracks), in the follicle (n¼ 397 tracks), and within 50mm of the
capsule (n¼ 343 tracks). Data pooled from four experiments. Open circles
represent measurements from individual cell tracks; red bars indicate overall
mean values and P values are marked in the ﬁgures as *Po0.05, **Po0.01,
***Po0.001 and ****Po0.0001 using Mann–Whitney U-test. (e) CMTMR-
labelled Tconv cells adoptively transferred 24h before imaging and tracked
with Tregs over 12min. Still image (top left, scale bar, 30mm) and
corresponding tracks (top right) of Tconv cells (red) and Tregs (green) in the
T-zone. Lower panels: magniﬁed views of representative individual Tconv cells
and endogenous Tregs (scale bar, 20mm). Asterisks mark cellular processes.
See Supplementary Video 4. (f) Velocities of individual Tregs (n¼ 217 tracks)
and Tconvs (n¼ 166 tracks) in the T-zone. Data pooled from three
experiments. (g) Tconvs (red) and Tregs (green) in the absence of antigen;
right panel pseudocoloured to highlight areas of contact; scale bar, 10mm.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7219
2 NATURE COMMUNICATIONS | 6:6219 | DOI: 10.1038/ncomms7219 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
B cells and CMTMR-labelled CD4þ CD25 T (Tconv) cells
revealed that Tregs are abundant in the T-cell zone, and are also
present at lower density within B-cell follicles and in the sub-
capsular space (Fig. 1b, Supplementary Video 1). Time-lapse
images of Tregs and associated tracks indicated little or no active
exchange between follicle and adjacent T-zone (Fig. 1c and
Supplementary Video 2). Their basal motility characteristics,
morphology and choreography clearly differed between locations
within the LN. Mean velocities of Tregs in the T-cell zone
(14.6±0.2 mmmin 1) were signiﬁcantly higher than follicular
Tregs (fTregs; 12.9±0.1 mmmin 1, Po0.001). Near or at the
capsule, Tregs migrated more slowly (9.5±0.2 mmmin 1;
Fig. 1d), many along collagen ﬁbres (Supplementary Fig. 1a and
Supplementary Video 3). The collagen-interacting Tregs migrated
more slowly than other Tregs within 50mm of the capsule
(Supplementary Fig. 1b). Deeper in the paracortex (450 mm
below the capsule), Tregs moved rapidly and extended the
cellular processes (Fig. 1e and Supplementary Video 4).
Within the T-cell zone, Tregs exhibited higher mean
velocities (13.9±0.2 mmmin 1) than colocalized Tconv cells
(12.0±0.2 mmmin 1, Po0.001; Fig. 1f). Moreover, Tregs
extended longer cellular processes than colocalized Tconvs
(Supplementary Fig. 1c); and fTregs were, on average, even
more elongated (Supplementary Fig. 1d). Close examination
under steady-state conditions in the absence of antigen revealed
cell–cell contacts between Treg and Tconv cells (Fig. 1g).
In summary, under steady-state conditions two non-overlapping
populations of Tregs explore the T-zone and the follicle. fTregs
have been identiﬁed previously as CD4þ Foxp3þ cells expressing
CXCR5 and Bcl6 (refs 24,25). Endogenous Tregs in the T-cell zone
are the most rapidly motile cells in the LN reported to date. In the
remainder of this report, we focus on the dynamics of Tregs
interacting with Tconvs and DCs in the T-zone.
Tregs engage resident DCs and Tconv cells. To image endo-
genous Tregs, resident DCs and Tconvs simultaneously, we
crossed Foxp3–eGFP male mice with CD11c–enhanced yellow
ﬂuorescent protein (CD11c–EYFP) reporter female mice26. In the
resultant F1 heterozygote females, 50% of Foxp3þ Tregs express
EGFP23, and EYFP is highly expressed in the LN-resident
DCs. CMTMR-labelled Tconv cells were then adoptively
transferred into these F1 mice, followed by LN imaging 24 h
after cells were allowed to equilibrate (Fig. 2a). The highly
dynamic endogenous Tregs (Fig. 2b,c and Supplementary
Video 5) interacted with CD11c–EYFPþ resident DCs, forming
transient contacts that lasted longer (3.3±0.4min) than
interactions between Tconvs and DCs (2.5±0.3min, Po0.004,
Fig. 2d). In the female heterozygous recipient population, only
half of the Tregs are GFPþ ; therefore, the actual mean frequency
of Treg:DC contacts would be twice that observed (Fig. 2e). Thus,
a single DC makes contact with 8.6±1.1 Tregs per hour. Given
the mean frequency of contacts between endogenous Tregs and
resident DCs and their average contact duration of 3.3min, our
measurements indicate that a LN-resident DC is in contact with
at least one Treg for 28.4min per hour—that is, nearly half of the
time. Conventional CD4 T cells brieﬂy interacted with Tregs
under basal conditions, encountering up to 13.4 Tregs per hour
(Fig. 2e) for an average of 1:36 (min:s). Therefore, a single Tconv
cell spends an average of 21.5min per hour (36% of the time) in
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Figure 2 | Tregs interact with LN-resident DCs. (a) Experimental design to visualize endogenous Tregs together with resident DCs and Tconv cells.
CMTMR-labelled Tconv cells from WT C57Bl/6 mice or CFPþ Tconv cells from b-actin–CFP mice were adoptively transferred 12 h or 4 days, respectively,
prior to imaging, into F1 of Foxp3EGFPCD11cEYFP mice. (b) Interactions among Tconv cells (red), resident DCs (yellow) and Tregs (green) under steady-
state conditions. Scale bar, 20mm, see Supplementary Video 5. (c) Superimposed Treg (green) and Tconv (blue) tracks, z compressed and normalized to
DC position at the centre (x, y¼0, 0). Data from CFPþ Tconv cells are shown; similar results were obtained with CMTMR-labelled Tconv cells. Cells
were tracked over 15:21 (min:s). (d) Contact durations between cell pairs: Tconvs interacting with DCs (n¼61); Tregs interacting with DCs (n¼67). Data
from CFPþ Tconv cells are shown, and are also representative of results with CMTMR-labelled Tconv cells. Three independent experiments, imaging
duration 41 h. (e) Observed contact frequencies with endogenous Tregs by labelled Tconvs (n¼47) and by resident DCs (n¼ 36), two experiments.
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contact with endogenous Tregs. These results demonstrate that
individual Tregs, although less abundant than Tconv cells, are
highly active and frequently encounter both DCs and Tconv
under basal conditions.
Activated migratory DCs are intercepted by Tregs. Resident
DCs in the LN constitutively present low levels of self-antigens,
and the T-cell receptor (TCR) repertoire of Tregs is skewed
towards self-antigen recognition27,28. Accordingly, we sought to
deﬁne the interactions between Tregs and activated, migratory
DCs from the periphery. Subcutaneous injection of CMTMR-
labelled lipopolysaccharide (LPS)-activated bone marrow-derived
DCs (LPS-DCs) into a Foxp3–EGFP animal followed by imaging
at 24 h revealed the highest density of DCs on and around
collagen ﬁbres just under the LN capsule (Fig. 3a). In this region
of the LN, Tregs readily interacted with and surrounded
immigrant DCs, while forming both brief and extended LPS-
DC:Treg contacts (Fig. 3b). Strikingly, some Tregs established
long-lived (up to 40min) contacts with LPS-DCs near the capsule
(Fig. 3c,d and Supplementary Video 6).
To investigate LPS-DCs and Tregs in the presence of antigen-
speciﬁc T cells but in the absence of cognate antigen, we
transferred labelled OTII cells (Fig. 3e) and observed that LPS-
DCs were surrounded by endogenous Tregs (Fig. 3f and
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Figure 3 | Tregs engage immigrant DCs near the lymph node capsule. (a) LPS-activated CMTMR-labelled DCs (red) imaged in the draining inguinal
lymph node 24 h after subcutaneous injection into a Foxp3EGFP mouse, showing immigrant DCs encountering and making contact with numerous
endogenous Tregs (green) directly beneath the collagen capsule (blue) of the lymph node (major tick marks¼ 20mm, 50mm z-stack). See Supplementary
Video 6. (b) Close-up image of a DC (red) near the collagen capsule and its interactions with several Tregs (green). Major tick marks¼ 10mm. (c) Space-
ﬁlled rendering of the DC (red) from b and an associated Treg (green) with track (grey, 39:27 (min:s) duration of imaging), showing close association
between Treg and DC (scale bar, 5 mm). (d) Time sequence (times shown in min:s) showing interactions of Tregs (green with grey tracks) engaging recently
immigrated DCs (red). (e) Experimental design to examine the effect of LPS-activated DCs on OTII Tconv cells and Tregs. LPS-activated DCs from an
ECFP mouse were injected into a Foxp3EGFP mouse followed by adoptive transfer of CMTMR-labelled OTII Tconv cells at 24 h and 2P imaging in the
draining lymph node 12 h later. (f) Snapshot showing adoptively transferred OTII Tconv cells (red), LPS-activated DC (blue) and Tregs (green). Scale bar,
30mm. See Supplementary Video 7. (g) Contact durations of Tregs with LPS-DCs (n¼ 110 contacts) and Tconvs with LPS-DCs (88 contacts). Data pooled
from three experiments each. (h) Effect of LPS-activated DCs on Treg velocities. Control velocities in the absence of LPS-DCs: Treg n¼ 296; OTII Tconv
cells n¼ 213. In the presence of LPS-DCs, OTII Tconv-cell velocity did not change appreciably (P¼0.7, n¼ 207, Mann–Whitney U-test), whereas Treg
velocity was reduced (n¼ 193). Data pooled from three experiments each. NS, not signiﬁcant.
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Supplementary Video 7). Under these conditions, average Treg
contact durations with LPS-DCs were signiﬁcantly longer (Fig. 3g;
5:53±0:38 (min:s)), as compared with both Tconv:LPS-DC
(2:53±0:22 (min:s)) and basal Treg:DC interactions
(3:14±0:28, both P o0.001; see for example, Figs 2d and 3g).
Consistent with results from wild-type (WT) Tconv cells,
endogenous Treg velocities were signiﬁcantly higher than
adoptively transferred OTII Tconv cells; however, endogenous
Tregs slowed signiﬁcantly as they interacted with LPS-DCs, while
OTII T-cell velocities were unaltered (Fig. 3h).
These results led us to examine whether the Treg:DC
interactions visualized near the LN capsule may lead to the
activation of endogenous Tregs29,30. Indeed, a higher percentage
of CD4 T cells were CD69þFoxp3þ in animals injected with
LPS-DCs, compared with control animals (Supplementary Fig. 2).
Contralateral LNs also had an increased number of
CD69þFoxp3þ cells. Our results thus demonstrate that
endogenous Tregs interact with activated LPS-DCs draining
into the LN from the periphery. Prolonged interactions take place
near the capsule, and reduce Treg velocity signiﬁcantly. We infer
that such prolonged interactions with immigrant LPS-DCs lead to
activation of endogenous Tregs.
Treg interactions with DC and Tconv during priming. To
examine Treg behaviour during an antigen-speciﬁc response, we
imaged OTII Tconv cells, Ova-pulsed DCs (Ova-DCs) and Tregs
at a critical point in T-cell activation, 12 h after the transfer of
antigen-speciﬁc OTII Tconv cells (Fig. 4a). This timing matches
the initial formation of naı¨ve CD4þ T-cell clusters around
antigen-bearing DCs (phase II of T-cell activation)16. As
expected, OTII Tconv cells formed clusters around Ova-DCs.
We further observed that Tregs form dynamic contacts with both
DCs and antigen-speciﬁc Tconv cells (Fig. 4b and Supplementary
Video 6). Although Tconv cells slowed as they interacted with
Ova-DCs, no signiﬁcant change in Treg velocity was observed
compared with steady-state conditions (Fig. 4c see for example,
Fig. 1d). Treg contact histories illustrate that Tregs spent more
time in contact with responding Tconv cells (Fig. 4d, red bars)
than with Ova-DCs (green bars), and were often in contact with
both (blue bars). However, in several instances, Tregs transitioned
from interacting with both the DC and responding T cell to
maintain an interaction with the responding Tconv cell alone
(Fig. 4e and Supplementary Video 8). Therefore, during T-cell
priming, Tregs engage dynamic clusters of DCs and Tconv cells
making frequent, brief contacts but without signiﬁcant slowing.
Blocking CTLA4 enhances clustering and limits Treg contacts.
CTLA4 expressed on Tregs is indispensable for maintenance of
immune homoeostasis, and treatment with a blocking antibody
leads to T-cell-mediated autoimmune disease5–8. Based on this,
we examined the effect of blocking CTLA4 on the dynamics of
Tregs during an antigen-speciﬁc T-cell response. Using the T-cell
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Figure 4 | Dynamics of Tregs during antigen-speciﬁc Tconv priming. (a) Experimental design to examine endogenous Treg behaviour during an immune
response. Ova-pulsed DCs were adoptively transferred into Foxp3EGFP mice 24 h prior to transfer of CMTMR-labelled OTII Tconv cells; imaging was
performed 12 h after OTII T-cell transfer. (b) Tconv-DC clusters. Still image showing DCs (blue), OTII Tconv cells (red) and Tregs (green). Scale bar, 50mm,
see Supplementary Video 8. (c) Tconv and Treg velocities. Mean track velocities of OTII T cells were separated into those that interacted with a DC
(DCþ OTII, n¼99) and those that did not (DC OTII, n¼426). Treg velocities, n¼811. Data are pooled from three experiments. (d) Contact history map
for 14 representative Tregs. Each horizontal bar represents time when a single Treg was alone (grey), in contact with a Tconv (red), in contact with
a DC (blue) or in contact with DC:Tconv pairs (green). (e) Close-up images of Treg–Tconv-cell contacts (white arrows) in the vicinity of a DC. The panel
shows three-way rotations at two time points, 67 s apart. Scale bar, 10mm.
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priming protocol of Fig. 4, we injected antigen-primed Foxp3EGFP
mice with aCTLA4 or isotype control (ITC) antibody 30min
after transfer of OTII Tconvs and 4 h before imaging (Fig. 5a).
OTII Tconv-cell dynamics were visibly altered following aCTLA4
treatment. Stable clusters of OTII T cells formed around Ova-
DCs, and Tregs were excluded from these clusters (Fig. 5b),
thereby reducing Treg interactions with DCs. aCTLA4 treatment
enhanced Tconv cluster stability and prevented Tregs from
making extensive DC contact (Supplementary Video 9), as
indicated by tracks of Tregs and OTII Tconv cells (green and red,
respectively, Fig. 5c) and contact history maps (Fig. 5d). In
aCTLA4-treated animals, the percentage of OTII Tconv cells that
remained in contact with an Ova-DC for over 20min (stable
contact) was signiﬁcantly higher (Fig. 5e). Indeed, OTII Tconv-
cell contacts with DCs were signiﬁcantly longer on average in the
presence of aCTLA4 (Po0.01), whereas Treg interactions with
Ova-DCs were not altered (Fig. 5f). Collectively, these results
indicate that OTII Tconv-cell clustering around Ova-DCs is
enhanced by blocking CTLA4.
CTLA4-B7 interactions contribute to Treg function. CTLA4 is
known to negatively regulate T-cell responses through interac-
tions with co-stimulatory B7 molecules, B7.1 (CD80) and B7.2
(CD86) on APCs31. In vitro and in vivo studies have shown that
Tregs can capture B7 ligands from DCs through a process of
trans-endocytosis that requires CTLA4 on Tregs32. To determine
whether aCTLA4 treatment alters the expression of co-
stimulatory ligands on DCs, we transferred LPS-DCs into
recipients that were treated with control (ITC) or aCTLA4
antibodies. By ﬂow cytometric analysis, CD80 and CD86 levels
were unaffected by aCTLA4 treatment (Supplementary Fig. 3).
Although the expression of CD80 and CD86 has been studied
most extensively in APCs, we conﬁrm previous observations33–35
that Tconv cells also express CD86 and upregulate CD80
and CD86 in vivo within 12–24 h of priming (Supplementary
Fig. 4a–d). Furthermore, after stimulation with anti-CD3/CD28
beads in vitro, CD80 and CD86 were upregulated in Tconv cells
that had divided at least once, and elevated levels were retained
through several divisions (Supplementary Fig. 4e). CTLA4
expression was also increased on Tconv cells that had
undergone at least one division, and as expected for activated T
cells CD69 expression was signiﬁcantly increased in proliferating
cells (Supplementary Fig. 5).
Upregulation of the CTLA4 ligands CD80 and CD86 in Tconv
cells suggested that suppressive CTLA4-B7 interactions may not
be exclusive to Treg:DC partners, but may contribute to
Treg:Tconv interactions. Using aCTLA4-blocking antibody and
the same dosing protocol as in Fig. 5a, we ﬁrst conﬁrmed a
previous study36 that OTII Tconv cells from the draining
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LNs proliferated more in aCTLA4-treated animals than in
ITCs (Fig. 6a,b). To complement our results using aCTLA
antibody we then used a genetic approach to address whether
Tregs mediate CD80/86-dependent Tconv interactions and
suppression. We compared proliferation and Treg suppression
of WT and CD80/86-double knockout Tconv cells in an APC-free
in vitro system (to exclude the effect of Tregs on DCs) using
anti-CD3- and anti-CD28-coated beads. WT and CD80/86
knockout Tconv cells proliferated comparably in response to
aCD3/CD28 beads (Fig. 6c). At a 1:1 ratio, WT Tregs inhibited
proliferation of WT Tconvs by 48±1.1% (mean±s.e.m.);
however, Treg suppression was signiﬁcantly reduced in CD80/
86 knockout Tconv cells (38±1.7%, P¼ 0.001, Fig. 6d). Thus, the
lack of CD80/CD86 makes Tconv cells less susceptible to
suppression by Tregs.
CTLA4 stabilizes Treg interactions with Tconv cells. Collec-
tively, the above results point towards an important functional
role of Treg CTLA4 interactions with CD80/86 on Tconvs. To
examine the choreography of these interactions, we compared
Treg:Tconv interactions under control conditions (ITC) and
following aCTLA4 treatment. In ITC-treated mice, it was clear
that Tregs interacted extensively with Tconvs, while also simul-
taneously interacting with DCs during antigen priming (Fig. 6e).
In contrast, during aCTLA4 treatment Tregs did not interact with
Tconv in DC clusters (Fig. 6f). To quantitatively analyze the role
of CTLA4 in stabilizing T-cell–T-cell interactions, we measured
contact durations under steady-state, inﬂammatory and priming
conditions. Steady-state Tconv:Treg cell contacts, although brief,
were signiﬁcantly longer than Tconv:Tconv-cell contacts
(Fig. 6g). Treg interaction times with Tconvs were prolonged in
the presence of LPS-DCs, implying that inﬂammatory conditions
may increase Tconv:Treg adhesion (Fig. 6g). During antigen
activation of OTII Tconv cells, Tconv:Treg interaction times were
substantially increased, and notably aCTLA4 treatment during
priming reduced Tconv:Treg contact durations to steady-state
values (Fig. 6h). These results indicate that the prolonged inter-
actions between Tconv and Tregs during inﬂammation and
priming are CTLA4 dependent.
In light of the high constitutive expression of CTLA4 by Tregs
and induced expression of CTLA4 by Tconvs, as well as
apparently conﬂicting evidence as to whether CTLA4 over-rides
or has no effect on the TCR-induced stop-signal37,38, we also
analyzed the effects of aCTLA4 treatment on OTII Tconv and
Treg velocities under both steady-state and priming conditions.
In the absence of cognate antigen, aCTLA4 treatment increased
Treg velocity modestly without signiﬁcantly altering Tconv-cell
velocity (Fig. 6i). Under priming conditions, DC-interacting OTII
Tconv velocities were reduced by aCTLA4 treatment, while at the
same time Treg velocities were increased relative to ITC
treatment (Fig. 6j). These results are consistent with the well-
known observation that velocities are reduced by cellular
interactions as cells cluster during priming14,16.
Discussion
Previous in vitro and in vivo studies have described both contact-
dependent and cytokine-mediated mechanisms of suppression by
Tregs11,39,40. In this study, we employed 2P imaging to directly
visualize and characterize the behaviour of endogenous Tregs and
their interactions with DCs and Tconvs. Two non-overlapping
populations of Tregs were observed in LN: one in the T-cell
zone and one in the follicle. The follicular population was
characterized by its position near the periphery of the LN,
colocalization with B cells and lack of exchange with Tregs in the
T-zone as deﬁned by colocalization with Tconv cells. fTregs
have been previously described as being retained in the B-cell
follicle by expression of CXCR5þ and high local concentrations
of CXCL13 (ref. 24), and have been shown to regulate germinal
centre formation25. Here we focus on T-zone Tregs that limit
Tconv-cell priming.
Several imaging studies used in vitro-expanded T cells to infer
the effects of Tregs on Tconv cells in LN, but without a full
consensus on mechanisms of immunoregulation17,18,21.
Tadokoro et al.18 concluded that Tregs inhibit CD4þ helper
T-cell interactions with DCs; Angiari et al.21 found that Treg
inhibition of T-cell:DC contacts and cluster formation was
restricted to the late phases of activation; whereas Mempel et al.17
observed that the addition of Tregs did not affect the long
duration interactions between CD8þ cytotoxic T lymphocytes
and antigen-presenting B-cell targets. Tang et al.19 imaged
adoptively transferred antigen-speciﬁc CD4þCD25þ Tregs
during immune response to islet antigen and concluded that
DC–Treg interactions limit helper T-cell activation. Recently,
Pace et al.22 indirectly demonstrated that Tregs suppress low-
avidity CD8þ responses to foreign antigens, showing that Treg
depletion did not alter the long lasting APC–T-cell interactions
induced by high-afﬁnity antigen, whereas short duration
interactions induced by low afﬁnity antigen were prolonged.
While reporting the role of Mst1 kinase in Tregs, Tomiyama
et al.20 suggested an alternative mechanism that antigen-speciﬁc
Tregs downregulate co-stimulatory molecules on DCs but are
unlikely to inhibit naı¨ve T-cell priming by physically competing
for DCs. However, in that study20 2P imaging was performed on
sliced LN instead of intact or in vivo LN, raising caveats regarding
damage to tissue architecture. Distinct from previous studies, our
results provide evidence for direct physical interaction among
endogenous Tregs with Tconv and APCs during an ongoing
immune regulation in LN and further highlight the role of
CTLA4 in coordinating these interactions. Figure 7 depicts a
summary of cellular choreography, surface markers and cell
interactions measured by contact durations under basal
conditions, during inﬂammation and during T-cell priming.
Under basal conditions in the absence of antigen (Fig. 7a top
left), Tconv cells move rapidly and in a random-walk search for
cognate antigen, sampling DCs with brief interactions41. In the
present study, we show that Tregs in the T-cell zone migrate even
faster than Tconv cells and engage both resident DCs and Tconv
cells in frequent, brief contacts. Tregs have elongated processes,
and contacts with Tconv are characterized by close apposition of
membranes. Although Tregs constitute only 5–10% of the total
number of T cells in the LN, our data indicate that individual
Tconvs and resident DCs interact directly with Tregs with high
frequency, and are in contact with at least one Treg 36 and 47% of
the time under basal conditions.
During inﬂammation (Fig. 7a top right), activated DCs from
the periphery enter the LN via afferent lymphatics and encounter
Tregs near the LN capsule. Activated DCs not pulsed with
exogenous antigen upregulate CD80 and CD86, and present self-
antigens in the context of MHCII refs 29,42. We demonstrate that
activated LPS-DCs form prolonged contacts with Tregs and that
the presence of LPS-DCs causes a signiﬁcant increase in the
proportion of Tregs that are activated. The interactions of Tregs
with LPS-activated DCs are reminiscent of prolonged CD4 T-cell
interactions with dermally derived antigen-presenting DCs
during priming16.
When antigen is present on migratory DCs (Fig. 7a bottom),
the cellular dynamics undergo marked changes that can be
divided into three phases as previously described16. We show the
dynamic behaviour and physical interaction of Tregs with Tconvs
and DCs during phase II (sustained contact). During this phase,
Tregs frequently interact with clusters of APC:Tconv but remain
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highly motile, suggesting that Tregs transiently scan these
clusters. Our results complement a recent study reporting
interaction behaviour of antigen-speciﬁc Tregs with CTLs and
APCs in a tumour model43. That study and our results suggest
that APCs displaying peptide–MHC complexes and co-
stimulatory molecules provide a platform for Tconv and Treg
interaction. Mechanistically, Tregs have been proposed to
regulate immune responses by decreasing CD80 and CD86 on
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APCs in a CTLA4 dependent manner, thus rendering APCs less
potent for further activation of Tconv cells32,44–46. However, in
our experiments, in vivo treatment with aCTLA4 did not alter
expression of the co-stimulatory ligands, CD80 and CD86 in
adoptively transferred and LN-recovered DCs. Several in vitro
APC-free assays have shown that Tregs are capable of direct
inhibition of Tconv-cell activation in a contact-dependent and
antigen-independent manner12,47. We conﬁrm this, and now
provide direct evidence for CTLA4-dependent physical
interactions between Treg:Tconv cells during immune
activation in vivo. Coinciding with phase II of antigen-speciﬁc
Tconv priming, when cognate Tconv cells interact stably with
DCs and high-density Tconv:DC clusters form (8–16 h), we show
that Tconv cells increase their expression of CD80 and CD86 on
activation (Fig. 7b), becoming potential targets for CTLA4-
mediated interaction with Tregs. In the presence of blocking
aCTLA4 antibody, Tregs appeared oblivious to both DCs and
Tconvs, resulting in larger and more stable Tconv:DC clusters
and contributing to enhanced T-cell proliferation in vivo.
Contact-dependent suppression mediated by B7 molecules on
activated T cells was previously proposed by Paust and Cantor39.
CD86 is expressed by naı¨ve CD4þ T cells, and we demonstrate
that both CD80 and CD86 are expressed by activated CD4þ
T cells. Using an in vitro, APC-free, genetic approach we show
that lack of CD80 and CD86 expression on Tconvs renders them
less susceptible to suppression by Tregs. Notably, Treg
suppression is not completely abrogated, because multiple
mechanisms for Treg suppression of Tconv-cell priming may
operate simultaneously11,48,49. Here we show that CTLA4 on
Tregs limits Tconv clustering around antigen-bearing DCs. We
demonstrate that Tregs physically engage Tconv cells that have
upregulated CD80 and CD86. Indeed, we found that aCTLA4
treatment disrupts both Treg–Tconv and Treg–DC cell
interactions at this early time point of T-cell activation
(Fig. 7c). Moreover, T-cell–T-cell synapses have been reported
to play a critical role in CD8 T-cell differentiation through active
exchange of cytokines during transient T–T synapse formation50.
In line with a recent report on the role of CTLA4 in stabilizing
Treg synapses in vitro51, our study delineates an important
functional role of Tregs to limit priming through CTLA4
interactions with upregulated B7 ligands on Tconv cells in vivo.
Finally, it has been suggested that CTLA4 may play a role in
the inhibition of TCR-induced T-cell stopping37,52, but this is
controversial38. In our study, treatment with aCTLA4 increased
steady-state Treg motility while having no effect on Tconv
motility. During antigen-speciﬁc immune activation, treatment
with aCTLA4 again enhanced Treg motility, but antigen-speciﬁc
Tconv exhibited a signiﬁcant decrease in velocity while forming
stable clusters with DCs. Considering the role of CTLA4 in
stabilizing Treg immune-synapses51, local exclusion of Tregs
when CTLA4 is blocked could contribute to enhanced Tconv-cell
clustering adjacent to DCs.
Methods
Mice, cell labelling and reagents. Mice were housed in a clean, pathogen-free
facility. Animal care and protocols were reviewed and approved by Institutional
Animal Care and Use Committee of the University of California, Irvine and the
animal ethics committee of Ghent University (ethical committee number 2013-
015), in accordance with European guidelines (directive 2010/63/EU; Belgian Royal
Decree of 6 April 2010). Male mice from the C57Bl/6 background were used at
8–12 weeks of age in donor/recipient experiments. Foxp3EGFP mice expressing
enhanced GFP along with Foxp3 were obtained from Jackson Laboratories
(Stock Number 006772). The CD11c–EYFP mouse strain expressing enhanced
YFP on the CD11c promoter26 was a kind gift from M. Nussenzweig (The
Rockefeller University, New York, NY, USA). Foxp3EGFP male mice were crossed
with CD11cEYFP female mice to generate F1 heterozygote females. Other mouse
strains included b-actin–cyan ﬂuorescent protein (b-actin–CFP; Stock Number
004218), TCR transgenic ova-IAb-speciﬁc OTII mice (Stock Number 004194),
CD80 / CD86 / mice (Stock Number 003610) and WT C57Bl/6 mice (Stock
Number 000664) were purchased from Jackson Laboratories. Cell labelling was
performed by suspending 4–6 million cells in 4ml of RPMI-1640 at 37 C,
quenching and washing twice with RPMI-1640 containing 10% FBS (Gibco).
Tconv cells were labelled with 10 mM 5-(and-6)-(((4-chloromethyl)benzoyl)amino)
tetramethylrhodamine (CMTMR) for 30min; for proliferation assays OTII Tconv
cells were labelled with 1.6 mM carboxyﬂuorescein succinimidyl ester (CFSE) for
7min; in some analyzed videos (not shown) DCs were labelled blue with 40 mM
CMF2HC for 40min (Molecular Probes, CellTrace series). The following antibodies
were purchased from BioLegend and were used at 0.2 mgml 1 for ﬂow-cytometry
and 100 mg per animal for in vivo blocking: anti-mouse CTLA4 (clone 9H10,
Syrian hamster IgG), ITC (hamster IgG), anti-mouse CD4 (clone GK1.5),
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Figure 7 | Summary of Treg, Tconv and DC dynamics. (a) Cellular choreography illustrating cell dynamics and the role of CTLA using cell shapes rendered
from 2P images (Tregs, green; Tconv, red; DCs, blue). Panels represent steady-state conditions (top left); inﬂammation (LPS DC; top right); T-cell
priming in three phases (middle); Tregs interacting with clusters during phase II under normal priming conditions (labelled ITC for isotype control, bottom
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T-cell priming. CD4 density refers to the local concentration of antigen-speciﬁc T cells near antigen-presenting DCs during phase II. (c) Colour-coded
diagram of measured contact durations among Tregs and Tconvs (top panel), and among Tcells and DCs (bottom panel). Each change in contact duration
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APC-conjugated anti-mouse Va2 (clone B20.1), anti-mouse CD69, anti-mouse
CD62L, anti-mouse CD80 (clone 16-10A1) and anti-mouse CD86 (clone GL1). All
adoptive transfers were performed under anaesthesia and mild restraint, via tail-
vein injection (T cells) or by subcutaneous injection (DCs) near a draining LN.
DC culture and Tconv-proliferation assays. Bone marrow-derived DCs for 2P
imagining were generated as described53. Brieﬂy, marrow was extracted from the
femur of 6–10-weeks-old mice and cultured in non-tissue culture-treated
polystyrene dishes for 9–10 days (Corning) using RPMI-1640 (Lonza)
supplemented with 1% L-glutamine, 10% foetal calf serum (Hyclone Inc.),
100Uml 1 penicillin, 100mgml 1 streptomycin, 2-bME and GM-CSF, IL-4 and
TNFa, as previously described53. For in vivo proliferation assays, IL-4 and TNFa
were excluded to enhance antigen uptake during Ova-pulsing. For activated DCs
and antigen-speciﬁc T–DC interaction imaging studies, DCs were treated with LPS
(100 ngml 1) alone or with LPSþOva (100 mgml 1) for 12–24 h prior to harvest
and injection. CD4þCD25 T cells (Tconv) were isolated from spleen and LNs of
6–10-week-old mice using negative selection (Miltenyi Biotec and StemCell
Technologies). For APC-free in vitro proliferation, CFSE-labelled WT Tconv cells
were co-cultured with anti-CD3/CD28-coated dynabeads (Life Technologies) at 1:1
ratio according to the manufacturer’s protocol. Tregs were added to Tconv at 1:1
ratio for suppression assays. CFSE dilution in live cells (Fixable Viability Dye
eFluor 780 negative gating; eBioscience) was analyzed using BD LSRII ﬂow
cytometer. For measuring the effects of aCTLA4 on in vivo proliferation, 2 106
Ova-DCs were injected subcutaneously into the footpad of WT mice; after 18 h
3 106 CFSE-labelled OTII Tconv cells were injected intravenously; popliteal LNs
were collected on day 3 of Tconv-cell transfer; LN from the contralateral hind limb
served as immunization control. CFSE dilution in single cells was analyzed by
gating on Va2þ CFSEþ population. Activation indices (AI) were calculated using
equation (1), as described54, where M values correspond to the number of cell
divisions assessed by CFSE dilution.
AI ¼ M9 þ
127
128M8 þ 6364M7 þ 3132M6 þ 1516M5 þ 78M4 þ 34M3 þ 12M2
1
128M8 þ 164M7 þ 132M6 þ 116M5 þ 18M4 þ 14M3 þ 12M2 þM1
ð1Þ
2P imaging. All images were acquired with excitation wavelengths between 890
and 910 nM. Two imaging systems were used. The primary system used is a cus-
tom-built 2P system based on an Olympus BX5 upright microscope, with excita-
tion generated by a tunable Chameleon femtosecond laser (Coherent). Dichroic
ﬁlters (495 and 560 nm) were arranged in series to separate blue, green and red
signals, and images were collected as previously described55 at UC-Irvine. EGFP
and EYFP signals are separated using a 520 nm dichroic ﬁlter. Additional data were
collected on a Zeiss inverted 710 2-photon system in the Inﬂammation Research
Center (IRC), VIB-U Gent with a Zeiss SP 485 nm, LP 490 nm, LP 555 nm, BP
565–610 nm ﬁlter combination arranged in series with blue, green and red
photomultiplier tubes. Both microscopes were ﬁtted with either a  20 (numerical
aperture (NA)¼ 0.95),  25 (NA¼ 1.05) or  60 (NA¼ 1.1) water-immersion
objectives, and equipped with three photomultiplier tubes, peristaltic heated
perfusion systems (Warner Instruments) and thermocouple-based temperature
sensors placed next to the tissue. All imaging was carried out on LNs maintained at
37±0.5 C and superfused with RPMI-1640 and medical grade carbogen gas (95%
O2 and 5% CO2). Size and velocity comparisons of endogenous Foxp3–EGFP T
cells from each microscope were analyzed separately and found to be nearly
identical with no signiﬁcant variation.
Data analysis. All image analysis was performed using Imaris software (Bitplane)
version 6.5–7.2. Cells were tracked manually and contact durations were measured
with three-dimensional rotation to verify contacts. Stable contact formation was
deﬁned as any OTII T cell that remained in contact with one DC for a minimum of
20min. Unless otherwise noted, displayed images in all ﬁgures are maximal
intensity projections through the z-axis (‘top view’) of x–y–z stacks. Flow-cyto-
metry was performed on either a BD LSRII (UC-Irvine and VIB-UGent) or BD
LSR-Fortessa (VIB-UGent) and analyzed using FlowJo. Figures were generated
using Graphpad Prism and OriginPro8. Statistical analysis was performed using
Mann–Whitney test (unpaired sample, nonparametric); P values are marked in
ﬁgures: *Po0.05; **Po0.01; ***Po0.001 and ****Po0.0001.
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